Browse the corpus

The diffusing capacity of the lungs for carbon monoxide (DLCO), also known as the transfer factor for carbon monoxide (TLCO), measures the amount of carbon monoxide (CO) transferred per minute from alveolar gas to red blood cells (RBCs). This test provides critical insights into the lungs' ability to transfer oxygen from inhaled air to the bloodstream, making it essential for diagnosing and monitoring various pulmonary conditions.[1] Expressed in mL/min/mm Hg or mmol/min/kPa, the DLCO represents the volume of CO (in mL) transferred per minute for each unit of pressure difference (in mm Hg) across the total available functioning gas exchange surface in the lungs. Clinicians use inhaled CO for this test because of its strong affinity for hemoglobin (Hgb). Oxygen is not preferred due to its weaker interaction with Hgb. Cardiac output and overall body consumption also limit oxygen uptake. Due to CO's strong binding to Hgb, this gas' absorption is primarily limited by changes to the alveolar-capillary membrane rather than blood flow, enabling clinicians to evaluate the membrane's integrity. The DLCO helps evaluate patients with dyspnea, hypoxemia, emphysema, and interstitial lung disease (ILD) and serves as an early indicator for conditions like idiopathic pulmonary fibrosis (IPF) before spirometric changes are detectable. Additionally, DLCO determination helps clinicians monitor disease progression and therapy response and predict mortality. Any condition that reduces oxygen uptake will produce a similar decrease in CO uptake. Overlooking a low DLCO may be a missed opportunity for early intervention. The Fick equation for gas diffusion helps explain the physiologic factors that affect the DLCO. The respiratory membrane forms the diffusing barrier and separates air within the alveoli from blood flowing in the pulmonary capillaries. The membrane consists of the alveolar epithelium, interstitium, and capillary endothelium. The DLCO results from 2 main measurements: alveolar volume accessible during a 10-second breath hold (Va) and the rate of alveolar capillary blood CO uptake (Kco). The Fick equation is: Vg=[k*(A)(ΔP)] / T ,

The Fick equation for gas diffusion helps explain the physiologic factors that affect the DLCO. The respiratory membrane forms the diffusing barrier and separates air within the alveoli from blood flowing in the pulmonary capillaries. The membrane consists of the alveolar epithelium, interstitium, and capillary endothelium. The DLCO results from 2 main measurements: alveolar volume accessible during a 10-second breath hold (Va) and the rate of alveolar capillary blood CO uptake (Kco). The Fick equation is: Vg=[k*(A)(ΔP)] / T , where V is the volume of gas transferred per unit of time, K is the diffusion coefficient of the gas, A is the surface area for gas exchange, ΔP is the partial pressure difference of gas, and T is the membrane thickness. The Fick equation demonstrates that factors that influence the movement of gas molecules across the capillary membrane include the membrane's surface area and thickness, as well as the driving pressure or pressure gradient across the capillary membrane.[2][3] Alterations in respiratory membrane properties, Hgb levels, and capillary blood volume contribute to DLCO variations. Gas diffusion across the alveolar membrane increases when the membrane surface area, alveolar pressure gradient, or gas solubility increases or when the membrane becomes thinner. Conversely, membrane thickening or a decrease in the membrane surface area, alveolar pressure gradient, or gas solubility reduces gas diffusion across the alveolar membrane. Blood in the airways can also bind CO, and the DLCO may rise in the presence of hemoptysis and pulmonary hemorrhage. In contrast, anemia can decrease the DLCO. Measuring the DLCO is relatively simple and carries minimal risk, yet it provides critical insights into lung function, facilitating early detection and management of abnormalities. Incorporating DLCO testing into routine pulmonary evaluations can significantly improve patient outcomes and quality of care.

The risks of the DLCO test are minimal. Some patients may feel lightheaded during the test, and hypoxia may occur due to the cessation of supplemental oxygen and breath-holding. Infections may be transmitted if the equipment is improperly cleaned or droplet nuclei or body fluids inadvertently spread.